| Dr George M Miller, MD | |
|
8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 | |
| (512) 343-2292 | |
| (512) 343-2745 |
| Full Name | Dr George M Miller |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 26 Years |
| Location | 8140 N Mopac Expy Bldg Iii, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073555298 | NPI | - | NPPES |
| 8AG657 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | L7484 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Austin Medical Center | Austin, TX | Hospital |
| Round Rock Medical Center | Round rock, TX | Hospital |
| St David's Medical Center | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Anesthesiology Group Pllc | 0547256497 | 374 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
With predictions that drug-resistant ‘superbugs' could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
Researchers at the RUB and from Berkeley have used metal complexes to modify peptide hormones. In the Journal of the American Chemical Society, they report for the first time on the three-dimensional structure of the resulting metal-peptide compounds.
University of Bristol research into octopus vision has led to a quick and easy test that helps optometrists identify people who are at greater risk of macular degeneration, the leading cause of incurable sight loss.
› Verified 5 days ago
| Entity Name | Austin Anesthesiology Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598724304 PECOS PAC ID: 0547256497 Enrollment ID: O20040424000086 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
With predictions that drug-resistant ‘superbugs' could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
Researchers at the RUB and from Berkeley have used metal complexes to modify peptide hormones. In the Journal of the American Chemical Society, they report for the first time on the three-dimensional structure of the resulting metal-peptide compounds.
University of Bristol research into octopus vision has led to a quick and easy test that helps optometrists identify people who are at greater risk of macular degeneration, the leading cause of incurable sight loss.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George M Miller, MD 8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 Ph: (512) 343-2292 | Dr George M Miller, MD 8140 N Mopac Expy Bldg Iii, Suite 210, Austin, TX 78759-8837 Ph: (512) 343-2292 |
News Archive
Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.
With predictions that drug-resistant ‘superbugs' could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
Researchers at the RUB and from Berkeley have used metal complexes to modify peptide hormones. In the Journal of the American Chemical Society, they report for the first time on the three-dimensional structure of the resulting metal-peptide compounds.
University of Bristol research into octopus vision has led to a quick and easy test that helps optometrists identify people who are at greater risk of macular degeneration, the leading cause of incurable sight loss.
› Verified 5 days ago
Dr. John W Wages, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4100 Duval Rd, Bldg Iii Suite 200, Austin, TX 78759 Phone: 512-485-7200 Fax: 512-485-7224 | |
Allison Rae Losey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2554 | |
Dr. James Patrick Fogarty Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8140 N Mopac Expy Ste 3-210, Austin, TX 78759 Phone: 512-343-2292 | |
Vijay K. Ravula, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Gary L. Mihm, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Todd Paricio, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3801 N Lamar Blvd, Austin, TX 78756 Phone: 512-407-8444 Fax: 512-407-8097 | |
Dr. Rebecca R Porras, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2454 Fax: 512-454-1532 |